T-Capital focuses on cross-border transactions in the healthcare sector, supporting companies in cross-border financing, M&A, licensing & BD, and international strategic partnerships, connecting capital, industry, and innovation resources across different markets.
Internationalization for healthcare companies is more than just entering a new market. A truly valuable cross-border transaction needs to connect capital, technology, products, industrial capabilities, and market opportunities.
From the dual perspectives of the healthcare industry and capital transactions, T-Capital supports Chinese companies in finding overseas capital and industrial resources, and also helps overseas companies, products, and technologies find capital and industrial cooperation opportunities in the Chinese market.
We focus on the transaction itself, but even more on the long-term industrial value that can be created after the transaction.
Cross-border transactions are not limited to M&A. Depending on a company\'s international goals, different methods can be used, such as financing, licensing, strategic partnerships, joint ventures, or equity transactions.
Assisting healthcare companies with international development needs in finding overseas capital and strategic investment resources, and designing financing paths based on their development stage and cross-border requirements.
Supporting healthcare companies in overseas acquisitions, divestitures of foreign assets, and cross-border equity transactions, assisting them in finding suitable transaction partners and advancing transaction execution.
Connecting innovative drugs, medical devices, diagnostics, and other healthcare assets between China and overseas, seeking opportunities for licensing, co-development, and commercialization.
Helping companies find overseas industrial partners, technology partners, commercial partners, and other strategic resources to promote joint ventures, co-development, and long-term industrial cooperation.
Cross-border transactions can occur between different markets. T-Capital seeks connections with industrial and capital value based on the actual needs of the project.
Supporting Chinese healthcare companies with international strategies in finding overseas capital, technology, products, channels, and industrial cooperation opportunities.
Assisting overseas healthcare companies, technologies, and products in finding Chinese capital, industrial partners, and commercialization opportunities.
Connecting capital, companies, technologies, products, and industrial resources across different markets based on specific transaction needs to find valuable cooperation opportunities.
Engage with capital providers who have an international perspective and industrial resources to support a company\'s global expansion and capital needs.
Acquire the innovative assets and technological capabilities needed for business development through cross-border licensing, co-development, and industrial cooperation.
Find new markets and commercialization opportunities through industrial cooperation, commercial partnerships, or M&A.
Transform a one-time transaction into a long-term industrial collaboration, building international partnerships that continuously create value.
Cross-border transactions involve multiple stages, including industry assessment, partner screening, transaction structuring, business negotiations, and execution. T-Capital participates in key transaction nodes to move projects from opportunity to closing.
Understanding the target market, competitive environment, product value, and commercialization opportunities from a healthcare industry perspective to build a foundation for cross-border transaction judgment.
Screening for capital providers, industrial players, or transaction partners that are a true match based on the company's strategic goals, transaction needs, and resource requirements.
Assisting in structuring the transaction logic and cooperation framework for different transaction types such as financing, M&A, licensing, joint ventures, and strategic partnerships.
Participating in key stages such as communication with investors and transaction counterparties, business negotiations, due diligence coordination, transaction document discussions, and closing.
Product lifecycles, regulatory environments, business models, and industry chain structures vary significantly across different healthcare sectors. Industry understanding is the basis for effective matching in cross-border transactions.
Innovative drugs, drug discovery platforms, drug candidates, and related biotechnology assets.
Innovative medical devices, high-value consumables, implantable products, and related technologies.
IVD, molecular diagnostics, testing technologies, and related diagnostic products.
Medical services, specialty services, and healthcare service platforms.
Companies and assets related to artificial intelligence, digital health, and health information technology.
Consumer health, wellness management, and other related fields in the broader health industry.
The transaction structure and execution path for each cross-border project are different. We start from the company\'s actual goals, rather than applying a fixed transaction model.
Clarify which market the company wants to enter, what resources it is seeking, and the core problems the cross-border transaction needs to solve.
Outline the cooperation model, transaction path, and target partners based on the company's development stage, target market, and transaction type.
Seek capital providers, industrial partners, technology providers, or transaction counterparties for specific projects and match them based on project needs.
Assist in advancing business communication, transaction negotiations, due diligence coordination, and final transaction execution.
The value of cross-border transactions is ultimately validated through real deals. T-Capital\'s transaction experience covers various types, including financing, M&A, divestitures, licensing, and strategic partnerships.
For healthcare companies with international capital or industrial needs, we recommend clarifying the target market, cooperation purpose, and expected value in the early stages of the transaction, and then determining the most suitable transaction method.
View T-Capital Transactions →If your project involves overseas capital, industrial cooperation, licensing, or cross-border M&A, you can discuss it directly with the T-Capital team.
Submit Project Inquiry →T-Capital's cross-border services cover cross-border financing, M&A, licensing & BD, international strategic partnerships, and related industrial resource matching. The specific services are determined by the client's target market, transaction type, and project needs.
Yes. For Chinese healthcare companies with international development needs, T-Capital can find overseas capital providers, industrial partners, technology providers, product sources, and other strategic partners based on specific project requirements.
Yes. For overseas healthcare companies wishing to enter the Chinese market or find Chinese capital and industrial partners, T-Capital can assist in finding potential capital providers, industrial partners, and commercial collaborators based on the project specifics.
Yes. Cross-border licensing & BD is a key type of healthcare cross-border transaction. T-Capital can assist in finding suitable transaction and cooperation partners for licensing, co-development, and commercialization of products, technologies, or innovative assets.
Projects usually require a basic overview of the company or asset, transaction objectives, target market, product or technology details, commercialization progress, desired partnership resources, and expected transaction direction. Specific materials will be further determined by the transaction type.
Not necessarily. The core of a cross-border transaction is to address a company's international capital or industrial needs. This can be achieved through financing, equity transactions, licensing, joint ventures, co-development, or other strategic cooperation methods. The transaction structure must be designed based on the actual situation of the project.
Whether it\'s a Chinese company going global or global healthcare resources entering China, it can all start with a specific project discussion.
Contact Us →